US 8491893
Oncofetal antigen/immature laminin receptor antibodies for diagnostic and clinical applications
granted A61KA61K39/39558A61K47/6803
Quick answer
US patent 8491893 (Oncofetal antigen/immature laminin receptor antibodies for diagnostic and clinical applications) held by Quantum Immunologics, Inc. expires Mon Jul 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Quantum Immunologics, Inc.
- Grant date
- Tue Jul 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K39/39558, A61K47/6803, A61K47/6851, A61K47/6905